In the BioHarmony Drug Report Database
Epogen/Procrit, Procrit (epoetin alfa) is a protein pharmaceutical. Epoetin alfa was first approved as Epogen/Procrit on 1989-06-01. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms. It is known to target erythropoietin receptor.
Image (chem structure or protein)